Mon.Jan 22, 2024

article thumbnail

Bipartisan Lawmakers Signal Support for H.R. 1770

Drug Topics

The Equitable Community Access to Pharmacist Services Act seeks to ensure that seniors in rural and underserved communities have access to care and services from pharmacists for common infectious diseases.

224
224
article thumbnail

Obstetrical Patient Dies After Inadvertent Administration of Digoxin for Spinal Anesthesia

Pharmacy Times

The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine

181
181
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

RSV Hospitalization Risk Higher than Flu, Omicron Among Children

Drug Topics

Of the 2596 patients included in the study, the hospitalization rates were 31.5% for Omicron, 27.7% for influenza, and 81.7% for RSV.

Hospitals 185
article thumbnail

Pharmacists Are Transforming and Optimizing HIV Treatment

Pharmacy Times

Regardless of a pharmacist’s practice site or type, they play an integral role in ensuring the treatment success of patients with HIV.

162
162
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Why many more people are lining up for a flu shot than a Covid vaccine

STAT

America is over the Covid vaccine. Frantic lineups for scarce doses when Covid vaccines first became available have long since given way to widespread indifference. Each new round of boosters has drawn fewer bared arms than the round before it. The Centers for Disease Control and Prevention estimates that, as of Jan. 6, a mere 21.5% of Americans aged 18 and older and 11% of children have been vaccinated with the latest Covid vaccine.

Vaccines 145
article thumbnail

Report: Oncology, Immunology Projected to Lead Global Spending From 2024 to 2028

Pharmacy Times

The IQVIA Global Use of Medicines report for 2024 predicts that loss of brand exclusivity will negatively impact global market growth.

145
145

More Trending

article thumbnail

FDA wants classwide boxed warning on all commercial CAR-T therapies amid secondary cancer safety probe

Fierce Pharma

As many have feared, the FDA’s investigation into secondary T-cell cancers following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning. | As many have feared, the FDA's investigation into secondary T-cell malignancies following treatment with existing CAR-T therapies is poised to lead to a classwide black box warning.

FDA 141
article thumbnail

Opinion: The FDA and FTC need to crack down on TikTok and Instagram influencers pitching prescription drugs

STAT

In June, the Food and Drug Administration issued a warning letter about advertisements for the drug Recorlev for Cushing’s syndrome — its first in more than a year about webpages that make “false or misleading claims” about prescription drugs. More recently, in December the agency published guidance about TV and radio advertisements.

FDA 141
article thumbnail

Berberine May Reduce Inflammation of Lung Tissues in Patients With Metastatic Colorectal Cancer

Pharmacy Times

Berberine was associated with a reduction in inflammatory markers in the lungs, which was caused by the colorectal cancer.

139
139
article thumbnail

Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff

Fierce Pharma

Even as Gilead looks to become an oncology powerhouse in the coming years, the company on Monday recorded a major setback for its antibody-drug conjugate (ADC) Trodelvy. | The antibody-drug conjugate did not significantly improve survival outcomes compared with a chemotherapy alone in previously treated patients with metastatic non-small cell lung cancer.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: A Harvard course seeks to put food on the table in medical education

STAT

BOSTON — Doctors often don’t have a lot of time to chat with patients during medical appointments — which means that conversations about nutrition can wind up taking a backseat to other concerns. But during a recent weeklong course at Harvard T.H. Chan School of Public Health, preventive cardiologist Stephen Devries enlisted two dozen students in the mission to integrate nutrition into clinical medicine — changing the way medicine is taught and health care is delivere

Hospitals 138
article thumbnail

Eli Lilly's troubled NJ manufacturing site in hot water again over maintenance, quality control lapses

Fierce Pharma

Eli Lilly’s beleaguered manufacturing site in Branchburg, New Jersey, is back in the U.S. Food and Drug Administration’s crosshairs, Reuters first reported. | Following a July inspection, the FDA has uncovered eight new production deficiencies at Eli Lilly's Branchburg production plant. The observations run the gamut from problems in tracking manufacturing processes and quality controls to equipment calibration lapses and poor facility maintenance.

FDA 126
article thumbnail

STAT+: Gilead’s Trodelvy fails in lung cancer and raises new questions on antibody drug conjugate drugs

STAT

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed. The result, from a closely watched study called Evoke-01, will be seen as a disappointment by investors and oncologists alike.

article thumbnail

'Podnosis': What’s next for health tech investing in 2024?

Fierce Healthcare

The digital health and health tech sectors had a tough year in the wake of the COVID-19 pandemic, navigating through a turbulent hype cycle. | This week on "Podnosis," Sofia Guerra and Steve Kraus from Bessemer Venture Partners sat down with Fierce Healthcare's Heather Landi to discuss the health tech sector's performance, unraveling the factors that contributed to its current state.

126
126
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

STAT+: In ‘march-in’ rights, some see a tool to lower drug prices. Others see a threat to intellectual property

STAT

In the fall of 2020, Robert Sachs was prescribed a medication to treat prostate cancer that had metastasized into some of his bones. He welcomed the treatment, but was surprised by the $740 monthly copay cost, even after coverage from Medicare and supplemental insurance. So Sachs began reading about the drug, Xtandi , and found the annual list price at the time was about $156,000, or $427 a day, for men with commercial health insurance.

Insurance 134
article thumbnail

This startup is building a new model for primary and specialty care in Austin, Texas. It just secured $95.5M to fuel its growth

Fierce Healthcare

This startup is building a new model for primary and specialty care in Austin, Texas. It just secured $95.

125
125
article thumbnail

Medicare Advantage update pushes Wall Street to reset expectations

STAT

You’re reading the web version of Health Care Inc.,  STAT’s weekly newsletter  following the flow of money in medicine.  Sign up  to get it in your inbox every Monday.  Summa wrestling for physician buy-in General Catalyst finally has the hospital system it wants. But there’s some skepticism that the venture capital firm will live up to its promises and get the required buy-in from physicians and other medical staff, my colleague Tara Bannow reports.

Hospitals 127
article thumbnail

ACIP Releases Updates On Vaccine Recommendations, 2024 Adult Immunization Schedule

Pharmacy Times

The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.

Vaccines 123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

New tool for tracing blood cells’ ancestry might one day help predict disease risk

STAT

The human blood system is in a constant state of turnover. First-line immune defenders, like neutrophils, need to be replaced after just four to eight hours, platelets can last a week, red blood cells up to four months, and some white blood cells, like memory B cells, live for decades. The heroic task of constantly replenishing these ranks, and making sure the balance of different types of blood cells is right, falls to a primitive reserve of stem cells that reside deep in the bone marrow.

article thumbnail

Impact of Bispecific Antibodies on Multiple Myeloma Treatment

Pharmacy Times

Experts discuss the impact of advances in the treatment of multiple myeloma on patient care.

article thumbnail

Sandoz makes its first post-spinout acquisition

pharmaphorum

Sandoz makes its first acquisition since spinning out of Novartis, buying a Lucentis biosimilar from Coherus that will boost its position in the US market.

119
119
article thumbnail

Early Experience Program Doses First Patient With Intravesical Gene Therapy at Urology Practice

Pharmacy Times

Access to gene therapies can pose challenges for patients.

122
122
article thumbnail

STAT+: FDA sets aggressive deadline for inspection overhaul

STAT

WASHINGTON — Food and Drug Administration officials hope to finish this year a massive overhaul of the way the agency inspects facilities that make drugs, medical devices, and food products, they said Friday. The reorganization was spurred by the FDA’s mishandling of the infant formula crisis. The agency was slow to inspect a major infant formula plant despite a whistleblower complaint about deadly bacterial contamination at the facility.

FDA 117
article thumbnail

Assessing Clinical Trial Efficacy vs Real-World Effectiveness in the Management of Multiple Myeloma

Pharmacy Times

There is a significant efficacy-effectiveness gap in standard-of-care regimens.

121
121
article thumbnail

Pharma waste management: Balancing cost, compliance, and environmental responsibility

pharmaphorum

Pharma waste management is crucial for balancing cost, compliance, and environmental responsibility in the healthcare industry. Explore strategies and best practices for effectively managing pharmaceutical waste, while ensuring regulatory compliance and minimising environmental impact.

113
113
article thumbnail

Three-Dose Hybrid Immunity Provided Older Adolescents With Robust Protection Against SARS-CoV-2 Infection

Pharmacy Times

Infection-induced immunity with 2-dose vaccination still offered protection against the circulating variant.

article thumbnail

Is drinking bad for your cholesterol?

The Checkup by Singlecare

Cholesterol gets a bad rap, but the truth is that your body needs cholesterol. The health issue that arises for many people is when levels get out of whack—meaning, your “bad” cholesterol is too high while the “good” kind is too low. Lots of factors can affect cholesterol levels, including drinking alcohol. But if you’re keeping an eye on your cholesterol levels, does this mean you can never have a drink?

111
111
article thumbnail

J&J's Balversa gets mixed approval in bladder cancer as FDA ratchets up scrutiny on subgroup data, patient survival

Fierce Pharma

When the FDA converts an accelerated approval into a full nod, it’s typically associated with a wider label for the drug at hand. | When the FDA converts an accelerated approval into a full nod, it's typically associated with a wider label for the drug at hand. But in the case of Johnson & Johnson’s Balversa, the FDA narrowed the use of the first-in-class bladder cancer drug in two ways and expanded it in another.

FDA 108
article thumbnail

Watch DSN: CVS Health's Sri Narasimhan discusses raising the bar for retail pharmacy expectations

Drug Store News

Sri Narasimhan, VP and head of enterprise customer experience at CVS Health, discusses using a customer-centric approach to cultivate higher retail pharmacy expectations among the public.

107
107
article thumbnail

Roche ducks out of AC Immune Alzheimer antibody alliance

pharmaphorum

End of the line for Roche’s 18-year alliance with Swiss biotech AC Immune, as it returns rights to Alzheimer's antibodies crenezumab and semorinemab

article thumbnail

Hostess packs on the love with Valentine’s Day roll out

Drug Store News

Valentine’s Day is just weeks away and Hostess is showing off some of its holiday-inspired treats, which include a Twinkies gift box.

105
105
article thumbnail

Next stage in GSK’s Zantac defense gets underway today

pharmaphorum

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients.

105
105
article thumbnail

Opinion: STAT+: Some countries are moving to digital prescription drug information for patients. The U.S. shouldn’t follow suit

STAT

Getting a new prescription can be overwhelming: medication schedules, foods to eat or avoid, interactions between different drugs. Having all of these details in accessible, printed documents keeps patients informed and mitigates the risk of medication errors. However, there’s a growing movement across the world to eliminate printed medication information, making it harder for patients to learn about the drugs that, in many cases, save their lives.